Literature DB >> 27760862

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G.

Sung-Min Kim1, Patrick Waters2, Mark Woodhall2, Yoo-Jin Kim3, Jin-Ah Kim1, So Young Cheon1, Sehoon Lee4, Seong Rae Jo4, Dong Gun Kim4, Kyeong Cheon Jung3, Kwang-Woo Lee1, Jung-Joon Sung1, Kyung Seok Park5.   

Abstract

BACKGROUND: Neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G (NMOSD-AQP4) is an inflammatory disease characterised by a high female predominance. However, the effect of gender in patients with NMOSD-AQP4 has not been fully evaluated.
OBJECTIVE: The aim of this study was to determine the effect of gender in clinical manifestations and prognosis of patients with NMOSD-AQP4.
METHODS: The demographics, clinical and radiological characteristics, pattern reversal visual evoked potential (VEP) test results, and prognosis of 102 patients (18 males) with NMOSD-AQP4 were assessed.
RESULTS: Male patients had a higher age at onset (48.7 vs 41 years, p = 0.037) and less optic neuritis as the onset attack (17% vs 44%, p = 0.026), higher tendency to manifest as isolated myelitis over the follow-up period (67% vs 28%, p = 0.005), fewer optic neuritis attacks per year (0.08 vs 0.27, p < 0.001), and shorter relative P100 latency on VEP testing (97.1% vs 108.3%, p = 0.001). Moreover, male gender was significantly associated with the absence of optic neuritis attacks over the follow-up period independent of their age of onset.
CONCLUSION: In NMOSD-AQP4 patients, gender impacts on disease onset age and site of attack. This may be an important clue in identifying NMOSD-AQP4 patients with limited manifestations as well as in predicting their clinical courses.

Entities:  

Keywords:  Neuromyelitis optica; age; anti-aquaporin4 antibody; gender; multiple sclerosis; sex

Mesh:

Substances:

Year:  2016        PMID: 27760862     DOI: 10.1177/1352458516674366

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

Review 1.  Headache in Neuromyelitis Optica.

Authors:  Alina Masters-Israilov; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2017-04

2.  Male patients with neuromyelitis optica spectrum disorders: different clinical characteristics and worse steroid treatment response.

Authors:  Rui Li; Cong Li; Zhifeng Mao; Qiao Huang; Yaqing Shu; Yanyu Chang; Jingqi Wang; Yuge Wang; Wei Qiu
Journal:  Neurol Sci       Date:  2020-11-27       Impact factor: 3.307

3.  Different Characteristics of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Seropositive Male Optic Neuritis in China.

Authors:  Honglu Song; Huanfen Zhou; Mo Yang; Junqing Wang; Hongjuan Liu; Mingming Sun; Quangang Xu; Shihui Wei
Journal:  J Ophthalmol       Date:  2019-04-01       Impact factor: 1.909

4.  Prevalence and Incidence of Neuromyelitis Optica Spectrum Disorder in Korea: Population Based Study.

Authors:  Hye Lim Lee; Jae Young Kim; Jin Myoung Seok; Yoon Ho Hong; Nam Gu Lim; Ha Young Shin; Byung Jo Kim; Soon Young Hwang; Ju Hong Min; Byoung Joon Kim
Journal:  J Korean Med Sci       Date:  2020-05-04       Impact factor: 2.153

5.  Free-water diffusion tensor imaging detects occult periependymal abnormality in the AQP4-IgG-seropositive neuromyelitis optica spectrum disorder.

Authors:  Minchul Kim; Kyu Sung Choi; Sung Min Kim; Ji-Hoon Kim; Ryoo Chang Hyun; Inpyeong Hwang; Tae Jin Yun
Journal:  Sci Rep       Date:  2022-01-11       Impact factor: 4.379

6.  Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability.

Authors:  Young Nam Kwon; Boram Kim; Jun-Soon Kim; Heejung Mo; Kyomin Choi; Seong-Il Oh; Jee-Eun Kim; Tai-Seung Nam; Eun Hee Sohn; Sung Hyuk Heo; Sang Beom Kim; Key-Chung Park; Sung Sang Yoon; Jeeyoung Oh; Seol-Hee Baek; Byung-Jo Kim; Kyung Seok Park; Jung-Joon Sung; Jae Ho Jung; Seong-Joon Kim; Sung-Hye Park; Patrick Waters; Sung-Min Kim
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-10-28

Review 7.  Differential diagnosis of neuromyelitis optica spectrum disorders.

Authors:  Sung-Min Kim; Seong-Joon Kim; Haeng Jin Lee; Hiroshi Kuroda; Jacqueline Palace; Kazuo Fujihara
Journal:  Ther Adv Neurol Disord       Date:  2017-05-24       Impact factor: 6.570

8.  Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China.

Authors:  Qiao Huang; Jingqi Wang; Yifan Zhou; Hui Yang; Zhanhang Wang; Zhenwen Yan; Youming Long; Jia Yin; Huiyu Feng; Caixia Li; Zhengqi Lu; Xueqiang Hu; Wei Qiu
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

Review 9.  Mechanisms of sex hormones in autoimmunity: focus on EAE.

Authors:  Ninaad Lasrado; Ting Jia; Chandirasegaran Massilamany; Rodrigo Franco; Zsolt Illes; Jay Reddy
Journal:  Biol Sex Differ       Date:  2020-09-07       Impact factor: 5.027

10.  Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.

Authors:  Haeng-Jin Lee; Boram Kim; Patrick Waters; Mark Woodhall; Sarosh Irani; Sohyun Ahn; Seong-Joon Kim; Sung-Min Kim
Journal:  J Neuroinflammation       Date:  2018-10-31       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.